For: | Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, Cao GW. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol 2011; 17(38): 4258-4270 [PMID: 22090781 DOI: 10.3748/wjg.v17.i38.4258] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i38/4258.htm |
Number | Citing Articles |
1 |
Yang Deng, Yan Du, Qi Zhang, Xue Han, Guangwen Cao. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma. Cancer Letters 2014; 343(2): 161 doi: 10.1016/j.canlet.2013.09.041
|
2 |
Sima Besharat, Aezam Katoonizadeh, Abdolvahab Moradi. Potential Mutations Associated With Occult Hepatitis B Virus Status. Hepatitis Monthly 2014; 14(4) doi: 10.5812/hepatmon.15275
|
3 |
Evgeny V. Denisov, Tatiana S. Gerashchenko, Marina V. Zavyalova, Vasiliy N. Manskikh, Evgeny L. Choinzonov, Nadezhda V. Cherdyntseva, Vladimir M. Perelmuter. Hepatocellular Carcinoma. 2016; : 211 doi: 10.1007/978-3-319-34214-6_14
|
4 |
Shehua Qian, Olga Golubnitschaja, Xianquan Zhan. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA Journal 2019; 10(4): 365 doi: 10.1007/s13167-019-00194-x
|
5 |
Luzheng Liu, Jiacheng Chen, Fei Ye, Fengran Chu, Chaoluan Rao, Yong Wang, Yanggang Yan, Jincai Wu. Prognostic value of oxidative phosphorylation-related genes in hepatocellular carcinoma. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01129-3
|
6 |
Prakriti Sinha, Parul Sahu. Dynamics of Immune Activation in Viral Diseases. 2020; : 205 doi: 10.1007/978-981-15-1045-8_14
|
7 |
Tian-Tian CHEN, Sha-Li DU, Shi-Jun WANG, Li WU, Lu YIN. Dahuang Zhechong pills inhibit liver cancer growth in a mouse model by reversing Treg/Th1 balance. Chinese Journal of Natural Medicines 2022; 20(2): 102 doi: 10.1016/S1875-5364(22)60160-2
|
8 |
Véronique Loustaud‐Ratti, Jérémie Jacques, Marilyne Debette‐Gratien, Paul Carrier. Hepatitis B and elders: An underestimated issue. Hepatology Research 2016; 46(1): 22 doi: 10.1111/hepr.12499
|
9 |
Chun-che Lin, Mei-chin Yin. Clinical significance of circulating IL-10 and fibronectin levels in hepatocellular carcinoma patients with HBV infection. BioMedicine 2012; 2(3): 122 doi: 10.1016/j.biomed.2012.06.003
|
10 |
Yan Du, Xue Han, Yi-Bo Ding, Jian-Hua Yin, Guang-Wen Cao. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects. World Journal of Gastroenterology 2016; 22(29): 6565-6572 doi: 10.3748/wjg.v22.i29.6565
|
11 |
Tongai Gibson Maponga, Richard H. Glashoff, Hannali Vermeulen, Barbara Robertson, Sean Burmeister, Marc Bernon, Jones Omoshoro-Jones, Paul Ruff, Alfred I. Neugut, Judith S. Jacobson, Wolfgang Preiser, Monique I. Andersson. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01372-2
|
12 |
Yan Du, Jiaxin Xie, Wenjun Chang, Yifang Han, Guangwen Cao. Genome-wide association studies: inherent limitations and future challenges. Frontiers of Medicine 2012; 6(4): 444 doi: 10.1007/s11684-012-0225-3
|
13 |
Zu-Sen Wang, Li-Qun Wu, Xin Yi, Chao Geng, Yu-Jun Li, Ru-Yong Yao. Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-306
|
14 |
Bing Qiu, Bo Huang, Xi Wang, Jinlong Liang, Jinfa Feng, Yingjuan Chang, Dongfu Li. Association of TAP1 and TAP2 polymorphisms with the outcome of persistent HBV infection in a northeast Han Chinese population. Scandinavian Journal of Gastroenterology 2012; 47(11): 1368 doi: 10.3109/00365521.2012.725090
|
15 |
Qiang Xu, Nian-Jun Shi, Hao Zhang, Yan-Mei Zhu. Effects of combined general-epidural anesthesia and total intravenous anesthesia on cellular immunity and prognosis in patients with non-small cell lung cancer: A comparative study. Molecular Medicine Reports 2017; 16(4): 4445 doi: 10.3892/mmr.2017.7144
|
16 |
Ping Chen, Chengbo Yu, Wei Wu, Jinghua Wang, Bing Ruan, Jingjing Ren, Shigui Yang, Kaijin Xu, Liang Yu, Lanjuan Li. Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study. Hepatitis Monthly 2013; 13(1) doi: 10.5812/hepatmon.7604
|
17 |
Yaqin Zhang, Weihua Cao, Shiyu Wang, Lu Zhang, Xinxin Li, Ziyu Zhang, Yao Xie, Minghui Li. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence 2024; 15(1) doi: 10.1080/21505594.2024.2421231
|
18 |
Liping Chen, Qi Zhang, Wenjun Chang, Yan Du, Hongwei Zhang, Guangwen Cao. Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma. European Journal of Cancer 2012; 48(13): 1977 doi: 10.1016/j.ejca.2012.01.015
|
19 |
Hon-Yi Shi, King-Teh Lee, Hao-Hsien Lee, Wen-Hsien Ho, Ding-Ping Sun, Jhi-Joung Wang, Chong-Chi Chiu, William B. Coleman. Comparison of Artificial Neural Network and Logistic Regression Models for Predicting In-Hospital Mortality after Primary Liver Cancer Surgery. PLoS ONE 2012; 7(4): e35781 doi: 10.1371/journal.pone.0035781
|
20 |
Ran Xu Zhu, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut and Liver 2016; 10(3) doi: 10.5009/gnl15257
|
21 |
Nicholas Noverati, Rukaiya Bashir-Hamidu, Dina Halegoua-DeMarzio, Hie-Won Hann. Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress. International Journal of Molecular Sciences 2022; 23(7): 3917 doi: 10.3390/ijms23073917
|
22 |
Yasmin Badshah, Maria Shabbir, Sameen Zafar, Uzma Mussarat, Aamer Ikram, Sumbal Javed, Hashaam Akhtar. Impact of IL-12B Genetic Variants on Antiviral Treatment Response among Hepatitis B Patients in Pakistan. Livers 2023; 3(3): 494 doi: 10.3390/livers3030034
|
23 |
Hao Zhang, Xuebing Chen, Jian Zhang, Xianwei Wang, Huijuan Chen, Lin Liu, Shanling Liu. Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review). International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4909
|
24 |
Imen Ben Dhifallah, Kaouther Ayouni, Ghofrane Najjar, Hanene Chelbi, Amel Sadraoui, Walid Hammami, Henda Touzi, Henda Triki. Interleukin IL‐1B gene polymorphism in Tunisian patients with chronic hepatitis B infection: Association with replication levels. Microbiology and Immunology 2020; 64(7): 512 doi: 10.1111/1348-0421.12774
|
25 |
Min Deng, Mingkai Tong, Fanchun Fu, Dahai Wei. Comparative untargeted metabolomics analysis of serum metabolic alterations in patients infected with hepatitis B virus genotypes B and C. Arabian Journal of Chemistry 2023; 16(10): 105155 doi: 10.1016/j.arabjc.2023.105155
|
26 |
Yan Du, Xue Han, Rui Pu, Jiaxin Xie, Yuwei Zhang, Guangwen Cao. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Frontiers of Medicine 2014; 8(2): 217 doi: 10.1007/s11684-014-0326-2
|
27 |
Anil Arora, Praveen Sharma, Pankaj Tyagi, Vikas Singla, Veronica Arora, Naresh Bansal, Jay Toshniwal, Ashish Kumar. Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India. Journal of Clinical and Experimental Hepatology 2013; 3(4): 288 doi: 10.1016/j.jceh.2013.08.007
|
28 |
Queenie Fernandes, Varghese Philipose Inchakalody, Takwa Bedhiafi, Sarra Mestiri, Nassiba Taib, Shahab Uddin, Maysaloun Merhi, Said Dermime. Chronic inflammation and cancer; the two sides of a coin. Life Sciences 2024; 338: 122390 doi: 10.1016/j.lfs.2023.122390
|
29 |
Qiang Hou, Zhi-Jun Duan. Metabonomic window into hepatitis B virus-related hepatic diseases. World Journal of Hepatology 2016; 8(1): 1-8 doi: 10.4254/wjh.v8.i1.1
|
30 |
Zhong-Xia Wang, Chun-Ping Jiang, Yin Cao, Guang Zhang, Wei-Bo Chen, Yi-Tao Ding. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2015; 14(2): 178 doi: 10.1016/S1499-3872(15)60353-8
|
31 |
Li Zhou, Lin Lu, Max S Wicha, Alfred E Chang, Jian-chuan Xia, Xiubao Ren, Qiao Li. Promise of cancer stem cell vaccine. Human Vaccines & Immunotherapeutics 2015; 11(12): 2796 doi: 10.1080/21645515.2015.1083661
|
32 |
Ming Wang, Dong Xi, Qin Ning. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatology International 2017; 11(2): 171 doi: 10.1007/s12072-016-9779-5
|
33 |
Wenbin Liu, Guangwen Cao. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.99838
|
34 |
Manoochehr Makvandi. Update on occult hepatitis B virus infection. World Journal of Gastroenterology 2016; 22(39): 8720-8734 doi: 10.3748/wjg.v22.i39.8720
|
35 |
Oluwadamilola G. Osasona, Oluwatosin O. Oguntoye, Abiola O. Arowosaye, Lukman O. Abdulkareem, Moses O. Adewumi, Christian Happi, Onikepe Folarin. Patterns of hepatitis b virus immune escape and pol/rt mutations across clinical cohorts of patients with genotypes a, e and occult hepatitis b infection in Nigeria: A multi-centre study. Virulence 2023; 14(1) doi: 10.1080/21505594.2023.2218076
|
36 |
Yan Du, Tong Su, Yibo Ding, Guangwen Cao. Effects of Antiviral Therapy on the Recurrence of Hepatocellular Carcinoma After Curative Resection or Liver Transplantation. Hepatitis Monthly 2012; 12(10) doi: 10.5812/hepatmon.6031
|
37 |
Xiumin Zhang, Sibo Zhu, Wei Zhu, Aijun Li, Naishuo Zhu. A Newly Identified Natural Splice Variant ASN Enhances Hepatitis B Virus Amplification. Viral Immunology 2016; 29(1): 27 doi: 10.1089/vim.2015.0044
|
38 |
H. Li, L. Sun, X. Chen, W. Xiong, D. Hu, S. Jie. Microvesicle microRNA profiles and functional roles between chronic hepatitis B and hepatocellular carcinoma. Clinical and Translational Oncology 2014; 16(3): 315 doi: 10.1007/s12094-013-1078-1
|
39 |
Lin Tian, Chun-Mei Li, Yan-Fei Li, Tian-Ming Huang, Nai-Xia Chao, Guo-Rong Luo, Fa-Rong Mo. Laminarin from Seaweed (Laminaria japonica) Inhibits Hepatocellular Carcinoma Through Upregulating Senescence Marker Protein-30. Cancer Biotherapy and Radiopharmaceuticals 2020; 35(4): 277 doi: 10.1089/cbr.2019.3179
|
40 |
Yatian Fu, Yiyuan Zhang, Bee Luan Khoo. Liquid biopsy technologies for hematological diseases. Medicinal Research Reviews 2021; 41(1): 246 doi: 10.1002/med.21731
|
41 |
|
42 |
Yu Lu, Zhitong Wu, Qiliu Peng, Liping Ma, Xiaolian Zhang, Jiangyang Zhao, Xue Qin, Shan Li, William B. Coleman. Role of IL-4 Gene Polymorphisms in HBV-Related Hepatocellular Carcinoma in a Chinese Population. PLoS ONE 2014; 9(10): e110061 doi: 10.1371/journal.pone.0110061
|
43 |
Ci Song, Yao Liu, Lu Xu, Juan Wen, Deke Jiang, Jianguo Chen, Xiangjun Zhai, Zhibin Hu, Li Liu, Jibin Liu. Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma. Cancer Medicine 2016; 5(7): 1687 doi: 10.1002/cam4.712
|
44 |
Yunqing Chen, Dahai Wei, Min Deng. Comparative Analysis of Serum Proteins Between Hepatitis B Virus Genotypes B and C Infection by DIA-Based Quantitative Proteomics. Infection and Drug Resistance 2021; : 4701 doi: 10.2147/IDR.S335666
|
45 |
Bo Chen, Juan Tang, Yun‐Shan Guo, Yong Li, Zhi‐Nan Chen, Jian‐Li Jiang. Calpains are required for invasive and metastatic potentials of human HCC cells. Cell Biology International 2013; 37(7): 643 doi: 10.1002/cbin.10062
|
46 |
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, Tina Boortalary, Dina Halegoua-DeMarzio, Hie-Won Hann. Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cancers 2024; 16(4): 777 doi: 10.3390/cancers16040777
|
47 |
Yue Liu, Huasong Xia, Meng Li, Yuxin Chen, Wei Zhou, Yi Chen, Yanqing Wu, Liaqat Ali. Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/3522866
|
48 |
Ugo Moens, Marijke Van Ghelue, Bernhard Ehlers. Are human polyomaviruses co‐factors for cancers induced by other oncoviruses?. Reviews in Medical Virology 2014; 24(5): 343 doi: 10.1002/rmv.1798
|
49 |
Dahai Wei, Yongyi Zeng, Xiaohua Xing, Hongzhi Liu, Minjie Lin, Xiao Han, Xiaolong Liu, Jingfeng Liu. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics. Journal of Proteome Research 2016; 15(2): 487 doi: 10.1021/acs.jproteome.5b00838
|
50 |
Wei Wang, Hongyan Jia, Yue Wang, Weize Sun, Can Yang. Predictive Value of Inflammatory Cytokines in Early Pregnancy for
Liver Dysfunction in Pregnant Women with Hepatitis B. Hormone and Metabolic Research 2023; 55(01): 59 doi: 10.1055/a-1973-7255
|
51 |
Li Ao, Jinlin Shi, Yaowu Bai, Shan Zhang, Jianhui Gan. Effects of transcutaneous electrical acupoint stimulation on perioperative immune function and postoperative analgesia in patients undergoing radical mastectomy: A randomized controlled trial. Experimental and Therapeutic Medicine 2021; 21(3) doi: 10.3892/etm.2021.9615
|
52 |
Moon S Chen Jr, Julie Dang. Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control. World Journal of Gastroenterology 2015; 21(42): 11924-11930 doi: 10.3748/wjg.v21.i42.11924
|
53 |
Juan P. Cata, Maria Bauer, Telemate Sokari, María F. Ramirez, David Mason, Gregory Plautz, Andrea Kurz. Effects of surgery, general anesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer. Journal of Clinical Anesthesia 2013; 25(4): 255 doi: 10.1016/j.jclinane.2012.12.007
|
54 |
Reza Ghasemi, Seyed H. Ghaffari, Majid Momeny, Saeed Pirouzpanah, Mehdi Yousefi, Mohsen Malehmir, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Multitargeting and Antimetastatic Potentials of Silibinin in Human HepG-2 and PLC/PRF/5 Hepatoma Cells. Nutrition and Cancer 2013; 65(4): 590 doi: 10.1080/01635581.2013.770043
|
55 |
Milton J. Finegold, Dolores H. López-Terrada. Pathology of Pediatric Gastrointestinal and Liver Disease. 2014; : 547 doi: 10.1007/978-3-642-54053-0_14
|
56 |
Wei Li, Jun Han, Hong Wu. Regulatory T‐cells promote hepatitis B virus infection and hepatocellular carcinoma progression. Chronic Diseases and Translational Medicine 2016; 2(2): 67 doi: 10.1016/j.cdtm.2016.09.001
|
57 |
De-Fei Hong, Ying-Bin Liu, Shu-You Peng, Jin-Zhong Pang, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang. Management of hepatocellular carcinoma rupture in the caudate lobe. World Journal of Gastroenterology 2015; 21(26): 8163-8169 doi: 10.3748/wjg.v21.i26.8163
|
58 |
Jing-Jing Han, Yu Chen, Yu-Chen Nan, Yong-Lin Yang. Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report. World Journal of Clinical Cases 2021; 9(28): 8492-8497 doi: 10.12998/wjcc.v9.i28.8492
Abstract(721) |
Core Tip(509) |
Full Article(HTML)(2052)
|
Full Article (PDF)-1812K(235)
|
Full Article (Word)-481K(246)
|
Audio-195K(7)
|
Peer-Review Report-196K(96)
|
Answering Reviewers-211K(96)
|
Times Cited (0)
|
Total Visits (7524)
|
Open
|
59 |
Jae Hee Woo, Hee Jung Baik, Chi Hyo Kim, Rack Kyung Chung, Dong Yeon Kim, Guie Yong Lee, Eun Hee Chun. Effect of Propofol and Desflurane on Immune Cell Populations in Breast Cancer Patients: A Randomized Trial. Journal of Korean Medical Science 2015; 30(10): 1503 doi: 10.3346/jkms.2015.30.10.1503
|
60 |
Salimur Rahman, Mobin Khan, Muhammad M Hussain, Shahidul Islam, Nooruddin Ahmed. Relationship between Hepatitis B Viral Deoxyribonucleic Acid Load and Hepatocellular Carcinoma. Euroasian Journal of Hepato-Gastroenterology 2017; 7(1): 111 doi: 10.5005/jp-journals-10018-1228
|
61 |
Yuzhuo Wu, Junhe Zhang, Huaihong Zhang, Yufeng Zhai. Hepatitis B virus X protein mediates yes-associated protein 1 upregulation in hepatocellular carcinoma. Oncology Letters 2016; 12(3): 1971 doi: 10.3892/ol.2016.4885
|
62 |
Apostolos Koffas, Upkar Gill, Patrick Kennedy. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 490 doi: 10.1002/9781119211419.ch33
|
63 |
Chong Li, Ji Wang, Hong Zhang, Mingao Zhu, Feifei Chen, Yufeng Hu, Hudan Liu, Hong Zhu. Interferon-stimulated Gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma. Oncotarget 2014; 5(18): 8429 doi: 10.18632/oncotarget.2316
|